报价延迟最少15分钟:2026/04/26 04:41 EDT
常规时段
|
|
|
|
|
||||||||||||
|
|
|
|
|
0.6269 
|
|
|
| 价值评估 |
|
盈利(现时/预测)
-2.39/-0.76
|
|
企业价值
4.06M
|
| 资产负债 |
|
每股账面净值
2.39
|
| 现金流量 |
|
现金流量率
--
|
| 损益表 |
|
收益
0
|
|
每股收益
--
|
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
同行比较之报价最少15分钟延迟 (夜盘时段除外)
|
业务概览
|
|||
| Galmed Pharmaceuticals Ltd is a biopharmaceutical company. The company focuses on the development of Aramchol for combination therapy for GI oncological indications. The company is actively pursuing opportunities in the biotech and medtechspaces to expand and diversify its product pipeline targeting GI, cardiometabolic indications and other product candidates. |
